Verseon Corporation Additional Listing & Total Voting Rights (7969D)

TIDMVSN

RNS Number : 7969D

Verseon Corporation

02 May 2017

May 2, 2017

Verseon Corporation

("Verseon" or the "Company")

Additional Listing & Total Voting Rights

Verseon, a technology-based pharmaceutical company, announces that application has been made for 19,117 new Common Shares of par value $0.001 each (the "Common Shares") to be admitted to trading on AIM pursuant to regularly scheduled vesting of the restricted stock units (the "Issuance"). The Issuance is in connection with the Verseon Corporation 2015 Equity Incentive Plan and pursuant to the regularly scheduled vesting of previously granted restricted stock units.

Of the 19,117 Common Shares issued, 7,010 Common Shares have been issued to Dr. Thomas Hecht, Non-Executive Chairman of the Company, in relation to payment of his Director's fees in the form of restricted stock as has been previously disclosed, totalling 28,037 Common Shares vesting quarterly in equal proportions over a one year period. Following Admission, Dr. Hecht will hold 45,328 Common Shares, representing 0.030% of the Company's issued share capital.

Of the 19,117 Common Shares issued, 7,732 Common Shares have been issued to Grover Wickersham, Non-Executive Director of the Company, in relation to payment of his Director's fees in the form of restricted stock as has been previously disclosed, totalling 15,463 Common Shares vesting quarterly in equal proportions over a 6 month period. Following Admission, Mr. Wickersham will hold 15,463 Common Shares, representing 0.010% of the Company's issued share capital

The 19,117 new Common Shares issued pursuant to the Issuance will rank pari passu with the Company's existing Common Shares and admission to trading on AIM is expected to take place on 5 May 2017 ("Admission").

Total Voting Rights

Following Admission, the issued share capital of the Company will consist of 151,452,891 Common Shares. The Company does not hold any shares in treasury. Therefore the total number of Common Shares in the Company with voting rights will be 151,452,891. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact

 
 Verseon Corporation                www.verseon.com 
                                    +1 (510) 225 
 Tina Schlafly                       9000 
 
 Cenkos Securities (NOMAD and 
  Joint Broker) 
                                     +44 (0) 20 
 Neil McDonald / Beth McKiernan       7397 8900 
 
 Cantor Fitzgerald Europe (Joint 
  Broker) 
 Marc Milmo / Phil Davies /         +44 (0) 20 
  Callum Butterfield                 7894 7000 
 
 Mirabaud Securities LLP (Joint 
  Broker) 
                                    +44 (0) 20 
 Peter Krens                         7321 2508 
 

For financial and business media enquiries, please contact

 
 Buchanan Communications Ltd 
  (PR Advisers) 
 Henry Harrison-Topham / Jamie    +44 (0) 20 
  Hooper                           7466 5000 
 

For trade and pharma media enquiries, please contact

 
 Vane Percy & Roberts 
                         +44 (0) 1737 
 Simon Vane Percy         821 890 
 
 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  -------------------------------------------------------- 
 a)    Name                        Dr. Thomas Hecht 
----  --------------------------  ---------------------------- 
 2     Reason for the notification 
----  -------------------------------------------------------- 
 a)    Position/status             Non-Executive Chairman 
----  --------------------------  ---------------------------- 
 b)    Initial notification        Initial notification 
        /Amendment 
----  --------------------------  ---------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------- 
 a)    Name                        Verseon Corporation 
----  --------------------------  ---------------------------- 
 b)    LEI                         N/a 
----  --------------------------  ---------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------- 
 a)    Description of              Restricted stock grant of 
        the financial               Common Shares of par value 
        instrument, type            $0.001 
        of instrument 
 
        Identification              ISIN: USU9221J1098 
        code 
----  --------------------------  ---------------------------- 
 b)    Nature of the               Vesting of restricted stock 
        transaction                 units 
----  --------------------------  ---------------------------- 
 c)    Price(s) and volume(s)        Price(s)    Volume(s) 
                                     ----------  ---------- 
                                      -           7,010 
                                     ----------  ---------- 
----  --------------------------  ---------------------------- 
       Aggregated information 
 
        - Aggregated volume          7,010 
 
 
 d)     - Price                      - 
----  --------------------------  ---------------------------- 
 e)    Date of the transaction     29 April 2017 
----  --------------------------  ---------------------------- 
 f)    Place of the transaction    N/a 
----  --------------------------  ---------------------------- 
 
 
 1     Details of the person discharging managerial 
        responsibilities / person closely associated 
----  -------------------------------------------------------- 
 a)    Name                        Mr Grover Wickersham 
----  --------------------------  ---------------------------- 
 2     Reason for the notification 
----  -------------------------------------------------------- 
 a)    Position/status             Non-Executive Chairman 
----  --------------------------  ---------------------------- 
 b)    Initial notification        Initial notification 
        /Amendment 
----  --------------------------  ---------------------------- 
 3     Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
----  -------------------------------------------------------- 
 a)    Name                        Verseon Corporation 
----  --------------------------  ---------------------------- 
 b)    LEI                         N/a 
----  --------------------------  ---------------------------- 
 4     Details of the transaction(s): section to 
        be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transactions 
        have been conducted 
----  -------------------------------------------------------- 
 a)    Description of              Restricted stock grant of 
        the financial               Common Shares of par value 
        instrument, type            $0.001 
        of instrument 
 
        Identification              ISIN: USU9221J1098 
        code 
----  --------------------------  ---------------------------- 
 b)    Nature of the               Vesting of restricted stock 
        transaction                 units 
----  --------------------------  ---------------------------- 
 c)    Price(s) and volume(s)        Price(s)    Volume(s) 
                                     ----------  ---------- 
                                      -           7,732 
                                     ----------  ---------- 
----  --------------------------  ---------------------------- 
       Aggregated information 
 
        - Aggregated volume          7,732 
 
 
 d)     - Price                      - 
----  --------------------------  ---------------------------- 
 e)    Date of the transaction     29 April 2017 
----  --------------------------  ---------------------------- 
 f)    Place of the transaction    N/a 
----  --------------------------  ---------------------------- 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEALSFEDDXEFF

(END) Dow Jones Newswires

May 02, 2017 02:01 ET (06:01 GMT)